Fut, nem toboroz1. fázis
Phase I study of IAG933 in patients with advanced Mesothelioma and other solid tumors
Key facts
- Where
- Milan és Rozzano, OlaszországSee the 2 sites
- Phase
- 1. fázis
Where in Olaszország
- Fondazione IRCCS - Istituto Nazionale dei TumoriMilan, OlaszországNo longer taking part
- Humanitas Research HospitalRozzano, OlaszországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2023-508369-34-00
- Record updated
- 2026. augusztus 11.